Treatment of Epidemic Keratoconjunctivitis With 2% Povidone-iodine

Treatment of Epidemic Keratoconjunctivitis With 2% Povidone-iodine

The purpose of this study is to determine the outcomes of treating epidemic keratoconjunctivitis with 2% povidone-iodine.

The study design was a prospective interventional case series. Our institutional ethical committee approved the study protocol in April 2004. We performed this study between July 2004 and December 2009. During this period, there were 2 episodes of EKC epidemic. The first episode was in 2006 and the second in 2009.

Inclusion Criteria:

• patients who were diagnosed with EKC at the outpatient ophthalmic unit

Exclusion Criteria:

• children younger than six years
• women being pregnant or during lactation
• history of allergy to povidone-iodine
• prior ocular surgery
• contact lens usage and chronic eye diseases with current eye medications.